Clinical association analysis revealed that A1BG-AS1 is downregulated in HCC, and low A1BG-AS1 level is also associated with advanced tumor stage, microvascular invasion, and high tumor grade (Bai et al., 2019). Here, A1BG is linked to hepatocellular carcinoma.